Skip to content

Medical emergency? What to do

Report Identifies Schizophrenia Patients Likely to Receive Depot Medication

3-RXPublished April 26, 20072 min read

Key points

  • A report in the April 2007 issue of Psychiatric Services has identified a unique subgroup of schizophrenia patients in the United States who tend to receive depot antipsychotic medications.
  • Co-authors of the study are: Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, and William Montgomery, Eli Lilly and Co.; Stephen R.
  • Patients with schizophrenia can improve with long-term treatment, but they may relapse if they do not follow antipsychotic medication regimens.
  • Patient nonadherence to oral medication due to disorganization or disaffection with treatment has been difficult for clinicians to predict.

A report in the April 2007 issue of Psychiatric Services has identified a unique subgroup of schizophrenia patients in the United States who tend to receive depot antipsychotic medications.

The study, “Characteristics and Use Patterns of Patients Taking First-Generation Depot Antipsychotic or Oral Antipsychotic for Schizophrenia,” led by Lizheng Shi, professor of health systems management at Tulane University School of Public Health and Tropical Medicine, examined data from a large randomized study on the treatment of 2,327 schizophrenia patients in the United States between July 1997 and Sept. 2003.

Patients with schizophrenia can improve with long-term treatment, but they may relapse if they do not follow antipsychotic medication regimens. Patient nonadherence to oral medication due to disorganization or disaffection with treatment has been difficult for clinicians to predict. Depot medications are administered by injection every two to four weeks, eliminating the need for daily oral dosing. Use of depot medication for patients in the identified subgroup may help reduce relapses among these patients, the study suggests. This unique group of patients is more likely to include African-Americans and persons who are less likely to be veterans, have had previous psychiatric hospitalizations, were more likely to have been arrested, use alcohol and illicit substances, and show psychotic symptoms and disorganized thinking.

Co-authors of the study are: Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, and William Montgomery, Eli Lilly and Co.; Stephen R. Marder, West Los Angeles Veterans Affairs Medical Center, Los Angeles, Calif. and the School of Medicine of the University of California–Los Angeles.

Source: Tulane University

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.